Federal Signal (FSS)
(Delayed Data from NYSE)
$83.28 USD
-1.80 (-2.12%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $83.28 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth B Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$83.28 USD
-1.80 (-2.12%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $83.28 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth B Momentum B VGM
Zacks News
Federal Signal (FSS) Q1 Earnings Surpass Estimates
by Zacks Equity Research
Federal Signal (FSS) delivered earnings and revenue surprises of 14.71% and -4.12%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Federal Signal (FSS) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Federal Signal (FSS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Federal Signal Announces Buyback Program, Launches Website
by Zacks Equity Research
Federal Signal (FSS) rewards shareholders with a $75-million stock buyback program. It unveils a website to make consumers aware of the use of its products to contain the coronavirus outbreak.
Can Value Investors Consider Federal Signal (FSS) Stock?
by Zacks Equity Research
Federal Signal (FSS) stock may be a good choice for value-oriented investors right now from multiple angles.
Federal Signal (FSS) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Federal Signal (FSS) delivered earnings and revenue surprises of 11.63% and 1.59%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
ITT's Q3 Earnings and Revenues Beat Estimates, Rise Y/Y
by Zacks Equity Research
ITT's third-quarter earnings and revenues rise year over year on the back of solid performance of Industrial Process segment.
Federal Signal (FSS) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Federal Signal (FSS) delivered earnings and revenue surprises of 11.90% and 0.17%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Federal Signal (FSS) to Post Q3 Earnings: What's in Store?
by Zacks Equity Research
Federal Signal's (FSS) third-quarter 2019 earnings are likely to have gained from strength in its end markets. High effective tax rate and cost of sales are likely to have posed concerns.
Federal Signal (FSS) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Federal Signal (FSS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Honeywell (HON) Q3 Earnings Surpass Estimates, Revenues Miss
by Zacks Equity Research
Impressive traction in its aerospace and process solutions businesses and solid demand for commercial fire products drive Honeywell's (HON) Q3 results.
Zacks.com featured highlights include: MDU Resources, Gibraltar Industries, Chemed, Federal Signal and SolarEdge Technologies
by Zacks Equity Research
Zacks.com featured highlights include: MDU Resources, Gibraltar Industries, Chemed, Federal Signal and SolarEdge Technologies
New Strong Buy Stocks for October 7th
by Nitish Marwah
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Monday.
Buy These 5 Low Leverage Stocks to Stay Afloat in Crisis
by Zacks Equity Research
With Q3 reporting season knocking on the door, investors are eyeing stocks that exhibited solid earnings growth in the prior quarters. But one should consider the stocks' debt levels before investing.
Honeywell's (HON) Board Approves 10% Hike in Dividend Rate
by Zacks Equity Research
Honeywell's (HON) latest hike marks its 10th double digit increment in dividend rate since 2010. Such shareholder-friendly policies of the company reflect a strong liquidity position.
Zacks.com featured highlights include: Federal Signal, Hanger, PCTEL, Skyline and Pilgrim's Pride
by Zacks Equity Research
Zacks.com featured highlights include: Federal Signal, Hanger, PCTEL, Skyline and Pilgrim's Pride
5 Stocks With Recent Price Strength to Maximize Your Gains
by Nalak Das
Investors target stocks that have been on a bullish run lately. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.
3M Adds Rosenberger and Molex as Assembly Solution Partners
by Zacks Equity Research
The addition of 3M's (MMM) assembly solution partners in its EBO Connector will allow it to develop the technology for facilitating next-generation data center optical connectivity.
Honeywell & KE2 Therm to Cut Energy Costs for Retail Grocers
by Zacks Equity Research
Honeywell's (HON) partnership with KE2 Therm will help retail grocers to reduce energy costs and wastage apart from meeting regulatory instructions.
Danaher (DHR) Plans to Redeem $875M Worth of Senior Notes
by Zacks Equity Research
Danaher (DHR) intends to redeem $875 million worth of senior notes. Funds received from Envista will be used for note redemption.
Danaher's (DHR) Subsidiary Envista Closes IPO, Shares Up
by Zacks Equity Research
Danaher's (DHR) Envista closes its initial public offering and pays the proceeds to Danaher as part payment for its assets.
General Electric's (GE) Unit Rolls Out DeltaVision OMX Flex
by Zacks Equity Research
General Electric's (GE) latest microscope DeltaVision OMX Flex is capable of capturing cell division details with high precision and contrast.
Buy These 5 Low Leverage Stocks if You Want to Avoid Risk
by Zacks Equity Research
Statistically, companies prefer debt over equity since debt is easily available and cheaper than equity. Yet, debt ridden companies are more prone to bankruptcy in times of crisis.
Danaher's Subsidiary Envista Prices IPO, to Trade as NVST
by Zacks Equity Research
Danaher's (DHR) subsidiary, Envista, goes public with an initial offering of roughly 26.8 million shares.
Honeywell Process Reliability Advisor Chosen by Fujian Meide
by Zacks Equity Research
Honeywell's (HON) Process Reliability Advisor will deliver Fujian Meide Petrochemical with crucial operational data of its plant that would enable it to run the plant efficiently.
3M Launches 3M M*Modal CDI Engage One for Healthcare Market
by Zacks Equity Research
3M's (MMM) 3M M*Modal CDI Engage One offers real-time clinical insight to clinical documentation improvement specialists, clinicians and coding teams.